Scott M. Plesha files SEC Form 4 disclosures for BIODELIVERY SCIENCES INTERNATIONAL INC. They have made 5 open-market trades across 1 company since 2019, most recently 2025-07-02.
CIK 0001726687
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BDSI | SELL | 2020-05-18 | 2020-05-20 | $4.52 | $68K | +3.2% | -0.1% | +9.1% |
| BDSI | SELL | 2020-03-18 | 2020-03-18 | $3.55 | $53K | +21.5% | +38.4% | +45.9% |
| BDSI | SELL | 2020-01-21 | 2020-01-23 | $5.77 | $87K | -10.0% | -9.5% | -27.4% |
| BDSI | SELL | 2019-12-11 | 2019-12-13 | $6.36 | $318K | +9.0% | -12.3% | -42.0% |
| BDSI | SELL | 2019-11-18 | 2019-11-19 | $6.06 | $152K | +13.1% | +5.9% | -13.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.